A detailed history of Black Rock Inc. transactions in Incyte Corp stock. As of the latest transaction made, Black Rock Inc. holds 23,240,470 shares of INCY stock, worth $1.34 Billion. This represents 0.03% of its overall portfolio holdings.

Number of Shares
23,240,470
Previous 24,298,022 4.35%
Holding current value
$1.34 Billion
Previous $1.53 Billion 13.22%
% of portfolio
0.03%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$56.55 - $66.59 $59.8 Million - $70.4 Million
-1,057,552 Reduced 4.35%
23,240,470 $1.32 Billion
Q4 2023

Feb 13, 2024

BUY
$52.16 - $64.19 $2.72 Million - $3.34 Million
52,053 Added 0.21%
24,298,022 $1.53 Billion
Q3 2023

Nov 13, 2023

BUY
$57.77 - $65.93 $21 Million - $24 Million
363,573 Added 1.52%
24,245,969 $1.4 Billion
Q2 2023

Aug 11, 2023

BUY
$60.95 - $75.51 $198 Million - $245 Million
3,246,531 Added 15.73%
23,882,396 $1.49 Billion
Q1 2023

May 12, 2023

BUY
$70.23 - $86.01 $56.1 Million - $68.7 Million
798,475 Added 4.03%
20,635,865 $1.49 Billion
Q4 2022

Feb 13, 2023

BUY
$67.18 - $84.11 $12.9 Million - $16.2 Million
192,727 Added 0.98%
19,837,390 $1.59 Billion
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $38.7 Million - $48.5 Million
585,285 Added 3.07%
19,644,663 $1.31 Billion
Q2 2022

Aug 12, 2022

BUY
$66.18 - $83.18 $63.9 Million - $80.4 Million
966,289 Added 5.34%
19,059,378 $1.45 Billion
Q1 2022

May 12, 2022

SELL
$66.02 - $79.71 $16.1 Million - $19.4 Million
-243,569 Reduced 1.33%
18,093,089 $1.44 Billion
Q4 2021

Feb 10, 2022

BUY
$63.34 - $74.11 $58.6 Million - $68.5 Million
924,880 Added 5.31%
18,336,658 $1.35 Billion
Q3 2021

Nov 09, 2021

BUY
$68.67 - $84.02 $31.6 Million - $38.7 Million
460,500 Added 2.72%
17,411,778 $1.2 Billion
Q2 2021

Aug 11, 2021

BUY
$79.87 - $87.53 $1.35 Billion - $1.48 Billion
16,951,278 New
16,951,278 $1.43 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $12.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.